Becton, Dickinson and Company reports developments for a global medical technology business organized around medical essentials, connected care, biopharma systems and interventional products. Company news commonly covers fiscal results, guidance, dividends, share repurchases, debt retirement, executive appointments and strategy updates following the completed separation of the Biosciences and Diagnostic Solutions business.
BD updates also include product and customer developments across its care-delivery platforms. Recent themes include the BD® CentroVena One™ Insertion System for central venous catheter placement, BD Pyxis™ Pro medication dispensing technologies, BD Alaris™ Infusion Systems, vascular access products, medication management, patient-safety workflows and partnerships with health systems.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
BD (Becton, Dickinson and Company) announces its participation at the Bank of America Securities 2023 Health Care Conference on May 9, 2023, at 11:00 am Eastern Time. The live webcast of the presentation will be available on BD's investor relations website, and a replay will follow the event. BD, a leading global medical technology company, focuses on advancing health care through innovative solutions aimed at enhancing patient care and operational efficiency for health providers. With a workforce of approximately 77,000 employees, BD is committed to addressing critical global health challenges and improving outcomes. For more details, visit bd.com.